Jason Gaglia
Section Head, Clinical, Behavioral and Outcomes Research · Beth Israel Deaconess Medical Center
Credentials: · · ·
History
- Present
Clinical Section · Beth Israel Deaconess Medical Center
- Present
Clinical Translational Research Core · Beth Israel Deaconess Medical Center
- 2004–2006
Endocrinology, Diabetes, and Metabolism
- 2001–2004
Internal Medicine
- 1997–2001
Research
Nature · 2002 · 1,384 citations
Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
Review · The Lancet Diabetes & Endocrinology · 2020 · 158 citations
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
Journal of Clinical Investigation · 2011 · First of 8 authors · 157 citations
4 papers
- JS
4 papers
- RW
4 papers
4 papers
3 papers
- CG
3 papers
3 papers
3 papers
Grants
- 2022–2026
Early Detection of Type 1 Diabetes via Exosome Technology with Optoelectronics Lab-on-Chip: EXTOL
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3M · Brigham and Women's Hospital
Clinical trials
- 2019–2023
Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes
Principal investigator · Completed · Phase 1, Phase 2
Avotres Inc.
- 2013–2014
Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes
Principal investigator · Completed
Joslin Diabetes Center
- 2012
- 2026–2032
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Study chair · Not yet recruiting · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)